July 18, 2016
A study linking maximum daily doses of acetaminophen to acute liver failure will not be barred from multidistrict product liability litigation over the drug, even as a Pennsylvania federal judge acknowledged some flaws in how the data in the article was handled.
April 20, 2016
A woman suing Johnson & Johnson over her sister's death in the first bellwether trial in multidistrict litigation over the alleged liver damage risks of various Tylenol products on Wednesday told a Pennsylvania federal court that drugmakers must enhance label warnings as soon as there's reasonable evidence that the drug is associated with a risk.
April 19, 2016
A Pennsylvania federal judge on Tuesday for the most part shot down bids from Johnson & Johnson to keep evidence, such as promotional marketing or media reports, from the first bellwether trial in multidistrict litigation over the alleged liver damage risks of various Tylenol products.
March 03, 2016
A Pennsylvania federal judge Wednesday allowed most of the testimony by the consumers' marketing expert in the first bellwether trial in multidistrict litigation alleging Johnson & Johnson's Tylenol products carry risks of liver damage, blocking the expert from offering certain opinions but saying he was otherwise qualified.
June 15, 2015
Plaintiffs targeting Johnson & Johnson and its subsidiary McNeil-PPC Inc. in multidistrict litigation over the alleged liver damage risks of various Tylenol products argued Friday that the defendants should not be allowed to testify that their counsel or witnesses have themselves taken the drugs or suffered tragedies.
January 29, 2015
A Pennsylvania federal judge on Thursday set a late June trial date for the first bellwether case in multidistrict litigation alleging the acetaminophen in various Tylenol products from a Johnson & Johnson Inc. unit was responsible for users' severe liver damage.